AUSENCO WINS CANADIAN CONTRACT

AUSENCO WINS CANADIAN CONTRACT

AUSENCO will deliver the development plan for the potential re-start of Teck Resources Limited’s Quintette coal mine in northern British Columbia, Canada.

Ausenco has already commenced work on the initial stages of the $20million project and with further development approvals will net an additional $19 million in revenue.

The contract involves detailed engineering design of the facility, procurement of materials and equipment, project and construction management and pre-commissioning of the mine.

Ausenco CEO Zimi Meka (pictured) says the new contract built on Ausenco’s previous work on the project, including the feasibility study and early engineering work.

“We have a strong working relationship with Teck Resources through our Vancouver based team and look forward to continuing to work with the team to deliver this important project,” he says.

The Quintette coal mine is located in British Colombia, Canada on the eastern side of the Rocky Mountain range and previously operated from 1982 to 2000.

Ausenco (AAX) shares are trading slightly up at $2.50.

Help us deliver quality journalism to you.
As a free and independent news site providing daily updates
during a period of unprecedented challenges for businesses everywhere
we call on your support

Advertisement

Related Stories

Brisbane biotech to trial world-first COVID-19 immunotherapy treatment

Brisbane biotech to trial world-first COVID-19 immunotherapy treatment

Brisbane and Seattle-based biotechnology company Implicit Bioscie...

Federal Court finds Google misled consumers on data collection

Federal Court finds Google misled consumers on data collection

The Federal Court has found Google misled consumers about persona...

Redflow charging up ahead of next-gen battery launch

Redflow charging up ahead of next-gen battery launch

Redflow (ASX: RFX) is gearing up to launch the next generation of...

Mayne Pharma breakthrough as FDA approves new contraceptive with plant-based estrogen

Mayne Pharma breakthrough as FDA approves new contraceptive with plant-based estrogen

A bet made by Mayne Pharma (ASX: MYX) in 2019 has paid off today ...